Mgr. Michal Šmída, Dr. rer. nat.
Research Group Leader Junior, Michal Šmída Research Group
office: bldg. E35/186
Kamenice 753/5
625 00 Brno
phone: | +420 532 23 5494 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 78
2018
-
Functional genomics to predict novel targets for personalized therapy of B-cell malignancies
Year: 2018, type:
-
T lymfocyty s chimerickým receptorem (CAR): revoluce v imunoterapii nádorů
Year: 2018, type:
-
Unexpected role of Aurora kinase inhibitors in CD20 expression
Year: 2018, type: Conference abstract
2017
-
B cells resistant to CD20 monoclonal antibodies display specific alterations in gene expression profile.
Year: 2017, type: Conference abstract
-
CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies
Year: 2017, type: Conference abstract
-
Cellular mechanisms regulating CD20 as a target of monoclonal antibody therapy in B-lymphoid malignancies
Year: 2017, type: Conference abstract
-
Exomové sekvenování v diagnostice dědičných trombocytopenií
Year: 2017, type:
-
Mechanisms of resistance to monoclonal antibodies in CLL
Year: 2017, type:
-
MEK inhibitors block growth of Ataxia Telangiectasia Mutated (ATM) mutant lung tumors
Year: 2017, type: Conference abstract
-
Význam a využití NGS v diagnostice dědičných trombocytopenií.
Year: 2017, type: Conference abstract